Want news about Cipla to land in your mailbox?


Cipla’s drug gets on to US anti-AIDS initiative
Mumbai, Aug. 16
Cipla’s paediatric version of triple-combination AIDS drug Triomune can now be purchased by the $15-billion PEPFAR global-initiative to treat the illness. This follows the tentative approval that paediatric Triomune got earlier this week from the US regulatory authority, the Food and Drug Administration (FDA).
Children below 12 years and infected with HIV/AIDS can now receive treatment under the initiative. It is the first fixed dose paediatric AIDS drug to get onto the PEPFAR programme, Mr Amar Lulla, Cipla’s Chief Executive Officer, told Business Line.
In 2003, the US President, Mr George W. Bush had mooted the President’s Emergency Programme for AIDS Relief (PEPFAR) over a five-year period to tackle the illness.
Triomune is a fixed-dose tablet that combines three AIDS medicines — lamivudine, stavudine and nevirapine. Lamivudine is the generic ingredient in GlaxoSmithKline’s AIDS medicine Epivir, stavudine is Bristol-Myers Squibb’s Zerit and nevirapine is Boehringer Ingelheim’s Viramune.
contd on page 2...
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
Anand Sudarshan
Managing Director and Chief Executive Officer
Manipal Education
Why is education sector attracting money, experts find out
Malvinder Singh
Chairman
Fortis Healthcare
Aim to keep 1:1 debt equity ratio post Parkway deal: Fortis
Dhruv Sawhney
CMD
Triveni Engineering & Industries
Triveni announces scheme of demerger of steam turbine biz
Hitesh Oberoi
COO
InfoEdge
Job mkt improving; see jump in hiring ahead: Info Edge
-
Most Read
-
Most Viewed
- 8 stocks that were buzzing last week, how to trade them now

- NMDC gets poor response; Ex-Disinvestment Secy defends govt

- IL&FS Trans IPO overbid; should you invest?
- Check out: Two top picks from Antique Stock Broking

- Why is education sector attracting money, experts find out
- KV Kamath relives his triumph,'08 crisis; bets big on India

- The big bull market has run its course, says Bill Bonner

- Stocks/sectors to park your funds ahead of the next upmove

- Pradip Overseas IPO subscribed; should you invest?
- Recent rights issue to fund Fortis' Parkway buy
- No follow-on offers in IOC, ONGC for now
Source: Business Line
- Fujitsu: the strange affair of Kuniaki Nozoe
Source: ft.com
- Indian harvest hopes sink sugar prices
Source: ft.com
- Tentative tone takes hold as investors seek direction
Source: ft.com

















